← Back to Vaccine Database

GX-19N

DNA based vaccine · VDDBV0352

Target & Classification

SARS-CoV-2SARS-CoV-2
DNA based vaccine
COVID-19
Phase 3

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials3

NCT IDPhaseDisease / Condition
NCT04445389 Phase 2COVID-19
NCT04715997 Phase 2COVID-19
NCT05067946 Phase 3COVID-19